Cite

HARVARD Citation

    Varlotto, J. et al. (2021). A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study. Oncologist. pp. 523-532. [Online]. 
  
Back to record